Eroxon, a topical gel intended to treat erectile dysfunction, may soon be available in the United States. The Food and Drug Administration authorized the marketing of the product as a medical device ...

An experimental therapy known as low-intensity shock wave treatment might improve erectile dysfunction, particularly for men with only mild to moderate sexual difficulties, a research review suggests.

ED is characterized by the inability to achieve or maintain an erection sufficient for sexual activity. It can be caused by various factors, including physical conditions such as cardiovascular ...

Add Yahoo as a preferred source to see more of our stories on Google. Though still a taboo topic, penis filler has grown in popularity in recent years as more men have come to embrace Botox, plastic ...

Erectile dysfunction can indicate heart disease years before cardiovascular issues arise. In fact, most heart problems don’t ...

Futura Medical has reported phase 3 data on its topical erectile dysfunction treatment MED3000, teeing it up to file for FDA approval of the therapy as an over-the-counter medicine by the end of the ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

Psychological factors are responsible for about 10%-20% of all cases of erectile dysfunction, or ED. It is often a secondary reaction to an underlying physical cause. In some cases, the psychological ...